International Stem Cell Corporation, a California-based biotechnology company developing novel stem cell-based therapies and biomedical products, has announced that Lifeline Skin Care, its operating subsidiary, has signed a distribution agreement with Grupo Venta Internacional, S.A de C. V., Mexico's largest distributor of aesthetic and reconstructive products.
Effective immediately, Grupo Venta Internacional will offer Lifeline's stem cell skin care products to health care professionals throughout Mexico, the second largest market for aesthetic skin care in Central and South America. Gabriela Gonzalez Alonso, President of GVI said: "Plastic surgeons and dermatologists in Mexico are very excited about the potential for stem cell skin care products. They're already familiar with the benefits of growth factors for skin rejuvenation, but the concept of stem cells elevates the technology to a whole new level. A brand that is backed by a biotech company adds even more credibility."
"Expanding international sales is a key part of our growth strategy," said Donna Queen, President of Lifeline Skin Care. "Initially Lifeline will be marketed only to physicians, which will lend credibility to the brand. The recommendation of a trusted health care professional is consistently rated as one of the most important considerations when selecting anti-ageing skincare products. For this reason we're especially pleased to be working with Grupo Venta Internacional."
Euromonitor International expects the Mexican skin care market to be worth approximately $2bn in 2014, with anti-ageing products being among the most popular categories.
